Good day, 360!
Here are our top investing ideas today. And don’t forget to join us in Market Masters – the hottest trading room around 🔥. Be the best prepared trader on the Street!
FOCUS LIST🔎
AMD – Up over 8% in pre, after reporting better than expected earnings and raised forecast on the back of investments in artificial intelligence
BNOX – Up over 20% in pre after announces successful end-of-Phase 2 meeting with the FDA on the development of BNC210 in Post-Traumatic Stress Disorder
MHUA – Up over 90% in pre after announcing it had facilitated the world’s second* 5G remote robot-assisted lobectomy
*together with Betterment
Your IRA, made to order
Choose where and when you want to retire, and a Betterment IRA can help make your money hustle all the way there.
HOTLIST🔥
AMD – Up over 8% in pre, after reporting better than expected earnings and raised forecast on the back of investments in artificial intelligence
Advanced Micro Devices Inc. (AMD) operates as a semiconductor company worldwide. It operates through Data Center, Client, Gaming, and Embedded segments.
In the after-hours yesterday, the company reported Q2 earnings which beat expectations. Perhaps more importantly the company raised its forecast for so-called AI accelerators — chips used to develop artificial intelligence models.
The company increased Q3 guidance, stating revenue will be roughly $6.7 billion in the third quarter vs analysts estimated $6.62 billion on average.
The stock traded up over 8% in the pre-market in reaction to the results.
The first target for bulls is the prior resistance area at $151.50. Beyond that $152 and the pre-market high at $152.84 come into play. Above that, targets are $155 and $160.
Below $151.50, targets to the downside are $150, $149, $148, $146.50, $145 then $142.50.
BNOX – Up over 20% in pre after announces successful end-of-Phase 2 meeting with the FDA on the development of BNC210 in Post-Traumatic Stress Disorder
Bionomics Limited (BNOX) is a clinical stage biopharmaceutical company that discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers.
In the after-hours the company announced the favorable outcomes of an EoP2 meeting with the FDA, supporting the advancement of its lead asset BNC210 for the treatment of PTSD into Phase 3 based on the positive results of the recently completed Phase 2b ATTUNE study.
Highlights include:
Successful End-of-Phase 2 (EoP2) meeting with U.S. Food and Drug Administration (FDA) provides a potential path to New Drug Application (NDA) submission for BNC210 for post-traumatic stress disorder (PTSD) with a single Phase 3 trial
Company received favorable FDA feedback on the Phase 3 study design and safety monitoring plans required for registration
Company plans to initiate the Phase 3 program in Q4 2024
The stock traded up over 20% in the pre-market in reaction to the news.
The first target for bulls is the prior resistance an $0.9399. Beyond that $1, $1.04, $1.12, $1.20, $1.26 and $1.30 come into play.
Below $0.9399, targets to the downside are $0.90, $0.8127, $0.80 and $0.70.
Did you know over 2,000 each day visit this room for trading education?
Why are you not one of them yet?
Join our real-money, real-time traders and educators as they break down Wall Street’s biggest moving stocks and options.
MHUA – Up over 90% in pre after announcing it had facilitated the world’s second* 5G remote robot-assisted lobectomy
Meihua International Medical Technologies Co. Ltd. (MHUA) engages in the research and development, manufacture, and sale of medical devices in the People’s Republic of China. The company offers class I, II, and III disposable medical devices.
In the pre-market this morning, the company announced that that its NT-2000 surgical path analysis system successfully supported the world’s second* 5G remote robot-assisted lobectomy.
This procedure, we believe the first of its kind in China’s Yangzi Delta area, was performed on July 15, 2024, at Yangzhou University Affiliated Hospital by a team from Shanghai Chest Hospital.
Mr. Yongjun Liu, Chairman of Meihua stated:
“We are honored that our cutting-edge technology could assist the advanced 3D imaging for surgical mapping in this sophisticated procedure.”
“Despite a physical distance of over 200 kilometers between the surgical team and the patient, the operation was executed seamlessly in just one hour, thanks to 5G technology and the precision of the robotic surgical system.
The stock traded up over 90% in the pre-market in reaction to the news.
The first target for bulls is the pre-market high at $2.07.
Beyond that, $2.20, $2.50 and $2.80 come into play.
Below $2.07 targets to the downside are $1.96, $1.49, $1.40, $1.30, $1.20, $1.10 and then a gap fill at $1.03.
MARKET NEWS 📰
P.S. Make sure you text “RAGE” to (888) 404-5747 to get all of our latest HOT STOCK ideas!
Questions or concerns about our products? Email Support@360wallstreet.io © Copyright 2022, RagingBull
DISCLAIMER: To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at https://ragingbull.com/disclaimer
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.
RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.
RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers.
RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.
*Sponsored Content: If you purchase anything through a link in this email other than RagingBull services, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals.
WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.
